<optgroup id="o6ukm"></optgroup>
<center id="o6ukm"><wbr id="o6ukm"></wbr></center>
<code id="o6ukm"></code>
<optgroup id="o6ukm"></optgroup><center id="o6ukm"></center>
<center id="o6ukm"></center>

Analyst Coverage

To our knowledge the following list presents the analysts publishing material commenting on Abcam. We provide this list for your convenience only and do not endorse or express any opinion on the reports these analysts publish.

Company Analyst
Berenberg Charles Weston
Investec Andrew Whitney
JP Morgan Cazenove David Adlington
Numis Securities Stefan Hamill
Panmure Gordon & Co Julie Simmonds
Peel Hunt Amy Walker
RBC Securities Nick Keher
Stifel James Mainwaring

About Abcam

Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

Read more +

Abcam Products

As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

Read more +

Investor Information

Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

Read more +

Abcam News

We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

Read more +